08:51 AM EDT, 05/17/2024 (MT Newswires) -- Immunome ( IMNM ) said Friday it has appointed Max Rosett as its Chief Financial Officer, effective May 9.

Rosett served as the Executive Vice President of Operations and has also been the Interim Chief Financial Officer since January.

He joined Immunome ( IMNM ) in October, having previously served as Morphimmune's Acting Chief Operating Officer, at the close of Morphimmune's merger with Immonome.

Price: 14.34, Change: -0.06, Percent Change: -0.42